[OTDev] Toxicology Ontology Perspectives and Roadmap

Barry Hardy barry.hardy at douglasconnect.com
Wed Dec 19 13:37:11 CET 2012


Based on an OpenTox : EMBL-EBI Industry Programme Workshop two papers
were published this year and are available online in Open Access mode
from www.altex.ch:

A Toxicology Ontology Roadmap ALTEX 29(2), 129 - 137 (2012)
and
Toxicology Ontology Perspectives ALTEX 29(2), 139 - 156 (2012)

Barry Hardy (Douglas Connect and OpenTox), Gordana Apic (Cambridge Cell
Networks), Philip Carthew (Unilever), Dominic Clark (EMBL-EBI), David
Cook (AstraZeneca), Ian Dix (AstraZeneca & Pistoia Alliance), Sylvia
Escher (Fraunhofer Institute for Toxicology & Experimental Medicine),
Janna Hastings (EMBL-EBI), David J. Heard (Novartis), Nina Jeliazkova
(Ideaconsult), Philip Judson (Lhasa Ltd.), Sherri Matis-Mitchell
(AstraZeneca), Dragana Mitic (Cambridge Cell Networks), Glenn Myatt
(Leadscope), Imran Shah (US EPA), Ola Spjuth (University of Uppsala),
Olga Tcheremenskaia (Istituto Superiore di Sanità), Luca Toldo (Merck
KGaA), David Watson (Lhasa Ltd.), Andrew White (Unilever), Chihae Yang
(Altamira)

I will be interested to hear from community members their interest and
suggestions in progressing this area.

best regards
Barry


Barry Hardy PhD
Director
Douglas Connect GmbH
Baermeggenweg 14
4314 Zeiningen
Switzerland




More information about the Development mailing list